These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8182625)

  • 21. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
    Vakily M; Amer F; Kukulka MJ; Andhivarothai N
    J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
    Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
    Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
    J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis.
    Hamilton SF; Campbell NR; Kara M; Watson J; Connors M
    J Rheumatol; 2003 Sep; 30(9):1948-50. PubMed ID: 12966595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL; Koren G; Shore A; Silverman ED; Laxer RM
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of methotrexate in rheumatoid arthritis: therapeutic implications].
    Bannwarth B; Péhourcq F; Lequen L
    Therapie; 1997; 52(2):129-32. PubMed ID: 9231507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis.
    Furst DE
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():20-5. PubMed ID: 8535644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
    Chen ML; McGuire WP; Lad TE; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):1-6. PubMed ID: 6698654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life-threatening interaction between the root extract of Pueraria lobata and methotrexate in rats.
    Chiang HM; Fang SH; Wen KC; Hsiu SL; Tsai SY; Hou YC; Chi YC; Chao PD
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):263-8. PubMed ID: 15936791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal measurement of methotrexate liver concentrations does not correlate with liver damage, clinical efficacy, or toxicity during a 3.5 year double blind study in rheumatoid arthritis.
    Fathi NH; Mitros F; Hoffman J; Straniero N; Labreque D; Koehnke R; Furst DE
    J Rheumatol; 2002 Oct; 29(10):2092-8. PubMed ID: 12375317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis.
    Dervieux T; Weinblatt ME; Kivitz A; Kremer JM
    Ann Rheum Dis; 2013 Jun; 72(6):908-10. PubMed ID: 23161901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood cell concentration of methotrexate in long-term therapy of inflammatory rheumatic diseases].
    Leeb B; Dunky A; Ogris E; Wohanka A; Schenk G; Fischer M; Tausch G; Eberl R
    Acta Med Austriaca; 1988; 15(5):140-4. PubMed ID: 3146207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total and free methotrexate pharmacokinetics in rheumatoid arthritis patients.
    Edno L; Bressolle F; Gomeni R; Bologna C; Sany J; Combe B
    Ther Drug Monit; 1996 Apr; 18(2):128-34. PubMed ID: 8721274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.